MAHSA ZADEH: Open Payments
NPI 1598380677 · PALM SPRINGS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,538 in 87 payments from 19 companies in 2025. Trend: 2023 $1,669 · 2024 $1,563 · 2025 $1,538
Food & beverage: $1,538
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $269 |
| Medtronic, Inc. | 23 | $230 |
| Novartis Pharmaceuticals Corporation | 15 | $228 |
| Boston Scientific Corporation | 11 | $140 |
| Novo Nordisk Inc | 4 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| PFIZER INC. | 3 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| Agios Pharmaceuticals, Inc. | 2 | $57 |
| Merck Sharp & Dohme LLC | 2 | $52 |
Products named: LEQVIO, FARXIGA, Wegovy, Kerendia, ELIQUIS, MICRA, REVEAL LINQ, LUX-Dx Insertable Cardiac Monitor.
Industry payments across CA — which companies pay providers there.
